首页> 外文期刊>Applied biochemistry and microbiology >The Engineering of a Yarrowia lipolytica Yeast Strain Capable of Homologous Recombination of the Mitochondrial Genome
【24h】

The Engineering of a Yarrowia lipolytica Yeast Strain Capable of Homologous Recombination of the Mitochondrial Genome

机译:能够线粒体基因组同源重组的解脂耶氏酵母酵母菌株的工程设计

获取原文
获取原文并翻译 | 示例
           

摘要

None of the studied eukaryotic species has a natural system for homologous recombination of the mitochondrial genome. We propose an integrated genetic construct pQ-SRUS, which allows introduction of the recA gene from Bacillus subtilis into the nuclear genome of an extremophilic yeast, Yarrowia lipolytica. The targeting of recombinant RecA to the yeast mitochondria is provided by leader sequences (5'-UTR and 3'-UTR) derived from the SOD2 gene mRNA, which exhibits affinity to the outer mitochondrial membrane and thus provides cotranslational transport of RecA to the inner space of the mitochondria. The Y. lipolytica strain bearing the pQ-SRUS construct has the unique ability to integrate DNA constructs into the mitochondrial genome. This fact was confirmed using a tester construct, pQ-NIHN, intended for the introduction of the EYFP gene into the translation initiation region of the Y. lipolytica ND1 mitochondrial gene. The Y. lipolytica strain bearing pQ-SRUS makes it possible to engineer recombinant producers based on Y. lipolytica bearing transgenes in the mitochondrial genome. They are promising for the construction of a genetic system for in vivo replication and modification of the human mitochondrial genome. These strains may be used as a tool for the treatment of human mitochondrial diseases (including genetically inherited ones).
机译:没有一个研究的真核生物具有线粒体基因组同源重组的天然系统。我们提出了一个整合的遗传构建体pQ-SRUS,它允许将来自枯草芽孢杆菌的recA基因引入极端嗜热酵母解脂耶氏酵母的核基因组中。重组RecA对酵母线粒体的靶向作用是由源自SOD2基因mRNA的前导序列(5'-UTR和3'-UTR)提供的,其对线粒体外膜表现出亲和力,从而提供RecA到内部的共翻译运输线粒体的空间。带有pQ-SRUS构建体的解脂耶氏酵母菌株具有将DNA构建体整合到线粒体基因组中的独特能力。使用测试仪构建体pQ-NIHN证实了这一事实,该构建体旨在将EYFP基因导入解脂耶氏酵母ND1线粒体基因的翻译起始区域。带有pQ-SRUS的解脂耶氏酵母菌株使基于线粒体基因组中带有解脂耶氏酵母的转基因的重组生产者的工程化成为可能。它们有望用于构建人类线粒体基因组体内复制和修饰的遗传系统。这些菌株可用作治疗人类线粒体疾病(包括遗传性疾病)的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号